9th RNA-Targeted Drug Discovery & Development Summit
November 10 – 12, 2026
Location :
The Westin Boston Seaport District
430 Summer Street,
Boston, MA 02210
United States
Website : https://rna-drugdiscovery.com/
Organisateur : Hansonwade
Accelerating Discovery & Translation of RNA-Targeted Small Molecules
Explore the Companies, Modalities and Breakthroughs Shaping the Future of RNA Therapeutics
Learn from the companies moving into the clinic, explore emerging modalities beyond splice modulation, and discover how the field is tackling its biggest challenges: selectivity, functional modulation and target validation.
The RNA-targeted small molecule field is reaching a critical inflection point.
Underscored by clinical advances including ReviR Therapeutics’ first participant dosed in a Phase 1 study of RTX-117 and Remix Therapeutics’ reporting positive Phase 1/2 data for REM-422, clinical programs are advancing, pharma interest is growing, and new approaches are expanding what is possible beyond traditional splice modulation.
Join 80+ RNA-targeted drug discovery leaders to:
- Connect with the companies shaping the future of RNA-targeted therapeutic
- Access new data from companies advancing RNA-targeted therapies toward the clinic
- Explore emerging modalities including RNA degraders, covalent binders, and epitranscriptomic approaches
- Tackle key challenges in target selection, functional modulation, and selectivity
- Benchmark strategies with leading biotech, pharma, and academic experts
